Stay updated on KarMMa Clinical Trial: bb2121 in RRMM
Sign up to get notified when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.

Latest updates to the KarMMa Clinical Trial: bb2121 in RRMM page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and eligibility criteria for the bb2121 treatment for multiple myeloma, while retaining the study identifier and revision number.SummaryDifference25%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check70 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check92 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to KarMMa Clinical Trial: bb2121 in RRMM
Enter your email address, and we'll notify you when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.